646 results on '"Calabrese, Massimiliano"'
Search Results
2. Choroid plexus volume in multiple sclerosis can be estimated on structural MRI avoiding contrast injection
3. Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis
4. SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
5. Signs and symptoms of COVID‐19 in patients with multiple sclerosis
6. ASCHOPLEX: A generalizable approach for the automatic segmentation of choroid plexus
7. Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis
8. Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)
9. Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity
10. Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis
11. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis
12. Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey
13. Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study
14. Explainable deep learning for decrypting disease signatures in multiple sclerosis
15. List of contributors
16. Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study
17. The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study
18. Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration Gap.
19. Smouldering‐Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions.
20. Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis.
21. Microstructural Modulations in the Hippocampus Allow to Characterizing Relapsing-Remitting Versus Primary Progressive Multiple Sclerosis
22. Explainable 3D-CNN for Multiple Sclerosis Patients Stratification
23. Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
24. Imaging and depression in multiple sclerosis: a historical perspective
25. The neural substrates of social cognition deficits in newly diagnosed multiple sclerosis patients.
26. Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study
27. False memories in relapsing remitting multiple sclerosis patients: A preliminary investigation with the DRM paradigm
28. CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis
29. The Contribution of Tumor Necrosis Factor to Multiple Sclerosis Progression Independent of Relapses
30. Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study
31. The time to include cognition in the multiple sclerosis concept of progression independent from relapse activity is now.
32. Explainable 3D-CNN for Multiple Sclerosis Patients Stratification
33. Microstructural Modulations in the Hippocampus Allow to Characterizing Relapsing-Remitting Versus Primary Progressive Multiple Sclerosis
34. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
35. Social cognition deficits and the role of amygdala in relapsing remitting multiple sclerosis patients without cognitive impairment
36. Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis.
37. Cognitive phenotypes predict response to restorative cognitive rehabilitation in multiple sclerosis.
38. CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis
39. Cognitive phenotypes predict response to restorative cognitive rehabilitation in multiple sclerosis
40. Cortical Gray Matter MR Imaging in Multiple Sclerosis
41. Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis.
42. The effect of fingolimod on focal and diffuse grey matter damage in active MS patients
43. A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study
44. Choroid Plexus Volume in Multiple Sclerosis can be estimated on structural MRI avoiding contrast injection
45. International Consensus on Smoldering Disease in Multiple Sclerosis using the Delphi Method (P11-3.013)
46. Effectiveness of Ocrelizumab in Primary PrOgRessive mulTiple sclerosis: a mUlticeNter, retrospective, real-world sTudY (OPPORTUNITY)
47. Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease
48. Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion Detection
49. Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)
50. Sars-CoV2 infection in pregnant women with multiple sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.